Full Text View
Tabular View
No Study Results Posted
Related Studies
Effect of Bosentan on Skin Fibrosis in Patients With Systemic Sclerosis
This study has been completed.
Study NCT00318175   Information provided by Heinrich-Heine University, Duesseldorf

First Received on April 24, 2006.   Last Updated on September 7, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Systemic Scleroderma
Skin Fibrosis
Hand Functionality
Additional conditions recognized in this trial
Fibrosis
Scleroderma, Diffuse
Scleroderma, Systemic
Sclerosis
More general conditions related to this trial
Connective Tissue Diseases
Pathologic Processes
Skin Diseases
Interventions listed in this trial
Bosentan (Tracleer)
Additional drug interventions recognized in this trial
Bosentan
More general drug interventions related to this trial
Antihypertensive Agents
Cardiovascular Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Heinrich-Heine University, Duesseldorf


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services